Demyelinating Disease and Hepatitis B Vaccination
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 24 (4) , 249-254
- https://doi.org/10.2165/00002018-200124040-00002
Abstract
The recent decision by the French government to compensate 3 recipients of hepatitis B vaccine preceding the onset of multiple sclerosis presumes a possible causal link and brings into question the...Keywords
This publication has 17 references indexed in Scilit:
- Vaccinations and the Risk of Relapse in Multiple SclerosisNew England Journal of Medicine, 2001
- Hepatitis B Vaccination and the Risk of Multiple SclerosisNew England Journal of Medicine, 2001
- Study of the safety, immunogenicity and seroconversion of a hepatitis-B vaccine in malnourished children of IndiaVaccine, 2000
- School-based hepatitis B vaccination programme and adolescent multiple sclerosisThe Lancet, 2000
- Comparative Safety of Two Recombinant Hepatitis B Vaccines in Children: Data from the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink (VSD)Journal of Clinical Epidemiology, 1998
- Major adverse reactions to yeast-derived hepatitis B vaccines—a reviewVaccine, 1998
- Comparison study of the immunogenicity and safety of 5- and 10- μg dosages of a recombinant hepatitis B vaccine in healthy infantsThe Pediatric Infectious Disease Journal, 1996
- The quest for trials on the efficacy of human vaccines. Results of the handsearch of VaccineVaccine, 1996
- Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescentsJournal of Adolescent Health, 1995
- Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccineThe Lancet, 1991